DENTSPLY SIRONA Inc. ( XRAY Quick Quote XRAY - Free Report) is scheduled to release first-quarter 2021 results on May 6, before the opening bell. In the last reported quarter, the company delivered an earnings surprise of 35.9%. Q1 Estimates
For the first quarter, the Zacks Consensus Estimate for revenues is pegged at $929.3 million, indicating a rise of 6.3% from the year-ago quarter. The consensus mark for earnings stands at 55 cents per share, suggesting an improvement of 27.9% from the prior-year quarter.
Factors to Note
DENTSPLY SIRONA’s Consumables segment is likely to have witnessed improvement in revenues in the first quarter. Rebound in sales of Restorative and Preventive might have aided the upside.
The company’s growth strategy has been focused on product innovation, and research and development (R&D), which may have benefited the company’s first-quarter performance. Apart from this, solid track record of innovation and a dedicated, passionate workforce are likely to have contributed to the to-be-reported quarter’s performance.
The company continued gaining from the launch of Axeos, Primemill and SureFil one as these received favorable customer feedback through the fourth quarter of 2020. Apart from these proven products, the company has an excellent new product pipeline that will positively impact 2021 and beyond. Consequently, first-quarter 2021 results are likely to reflect the impact of the same.
Sustained improvement in sales trends owing to reopening of dental offices and rise in patient visits might have favored the company’s performance in the to-be-reported quarter. However, DENTSPLY SIRONA’s significant international presence may have weighed on the company’s fourth-quarter performance. Foreign exchange headwind might have an impact on the to-be-reported quarter’s results. What Our Quantitative Model Suggests
Per our proven model, the combination of a positive
Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. This is the case here as you will see. Earnings ESP: DENTSPLY SIRONA has an Earnings ESP of +11.36%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. Zacks Rank: DENTSPLY SIRONA carries a Zacks Rank #2. Other Stocks Worth a Look
Here are some other medical stocks worth considering as these too have the right combination of elements to post an earnings beat this quarter.
AmerisourceBergen Corporation ( ABC Quick Quote ABC - Free Report) has an Earnings ESP of +0.23% and a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here. Owens & Minor, Inc. ( OMI Quick Quote OMI - Free Report) has an Earnings ESP of +2.41% and a Zacks Rank of 2. Becton, Dickinson and Company ( BDX Quick Quote BDX - Free Report) has an Earnings ESP of +1.16% and a Zacks Rank of 3. More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 77 billion devices by 2025, creating a $1.3 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 4 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2022. Click here for the 4 trades >>